THIS WEBSITE USES COOKIES

We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. We also share information about your use of our website with our social media, advertising and analytics partners. Our partners may combine this information with other data that you have provided to them or that they have collected in the course of your use of the Services.

Pharma

Photo credits: pixabay.com

Commented by Mario Hose on November 3rd, 2019 | 07:37 CET

BAYER, MERCK OR NOVARTIS - WHO BUYS NOXXON PHARMA?

Pharma

The therapy and cure of serious diseases is a large market with a high willingness to invest. Companies that are active in research and development need experienced teams and partners as well as a lot of liquidity and opportunities to carry out tests. Bayer, Merck and Novartis are well-known global players in the research and treatment of cancer. It is not uncommon for these companies to work with small partners and, if successful, to even acquire them. A transaction may be imminent.

Read